Abstract
Ryeqo is a combined formulation of relugolix, estradiol and norethisterone for the treatment of moderate to severe symptoms of uterine fibroids. This article outlines its efficacy, adverse effects and place in therapy.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have